Cargando...

Use of bevacizumab in recurrent glioblastoma

Glioblastoma (GBM) is the most common adult primary brain neoplasm. Despite advances in treatment, GBM continues to be associated with considerable morbidity and mortality as compared with other malignancies. Standard treatment for GBM results in survival of 12.9 months (95% CI: 12.3–13.7 months) wi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CNS Oncol
Main Authors: Ghiaseddin, Ashley, Peters, Katherine B
Formato: Artigo
Idioma:Inglês
Publicado: Future Medicine Ltd 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6088330/
https://ncbi.nlm.nih.gov/pubmed/25906439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!